Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ERASErasca Inc
| 0.4% | $5.03M 1.843M shares@ $2.74 avg price | Increased 8.43% |
IMTXImmatics N.v
| 0.35% | $4.405M 386,100 shares@ $11.41 avg price | Decreased -51.53% |
NARIInari Med Inc
| 0.3% | $3.725M 90,327 shares@ $41.24 avg price | Decreased -42.03% |
BDXBecton Dickinson & Co
| 0.3% | $3.663M 15,191 shares@ $241.1 avg price | New Position |
NXTCNextcure Inc
| 0.3% | $3.66M 2.672M shares@ $1.38 avg price | |
TMOThermo Fisher Scientific Inc
| 0.29% | $3.569M 5,770 shares@ $618.58 avg price | New Position |
EXASExact Sciences Corp
| 0.21% | $2.564M 37,637 shares@ $68.12 avg price | Decreased -79.3% |
IRONDisc Medicine Inc
| 0.17% | $2.032M 41,352 shares@ $49.14 avg price | Increased 41.35% |
BOLTBolt Biotherapeutics Inc
| 0.15% | $1.785M 2.754M shares@ $0.65 avg price | |
GPCRStructure Therapeutics Inc
| 0.14% | $1.703M 38,792 shares@ $43.9 avg price | Increased 335.14% |